Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Bitcoin (CRYPTO: BTC) is consolidating below $90,000, but BitMEX co-founder Arthur Hayes says the pause masks a powerful liquidity-driven move that could send the cryp
Via Benzinga · December 19, 2025
Natural gas intered Week 51 with a forecast -185 BCF storage withdrawal for Week 50 (December 12)-a record draw crushing the 5-year average.
Via Benzinga · December 19, 2025
When SoFi Technologies Inc. (NASDAQ:SOFI) announced its stablecoin launch on December 18, the market responded immediately.
Via Benzinga · December 19, 2025
Ethereum (CRYPTO: ETH) sits at the centre of one of crypto's longest-running debates: does it function as a true form of "cryptomoney" like Bitcoin or primarily as a t
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Cintas Corporation (NASDAQ: CTAS) stock slipped on Friday despite a modest earnings beat and higher full-year outlook.
Via Benzinga · December 19, 2025
BlackBerry Limited (NYSE:BB) shares are trading lower Friday. The company reported third-quarter financial results.
Via Benzinga · December 19, 2025
Energy Fuels' high‑purity dysprosium oxide passed initialchecks from an automotive manufacturer for downstream rare‑earth magnet production.
Via Benzinga · December 19, 2025
NVIDIA rose following reports the Trump administration has begun a review that could pave the way for shipments of H200 AI chips to China.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
KeyBanc's ratings and price forecasts for space and defense companies reflect strong growth potential in the sector.
Via Benzinga · December 19, 2025
Bitcoin (CRYPTO: BTC) is increasingly being treated as a monetary asset rather than a speculative trade, as institutional capital concentrates in BTC and leaves most a
Via Benzinga · December 19, 2025
Tesla shares have broken out. If what had been resistance converts into support it could set the stage for a move higher.
Via Benzinga · December 19, 2025
Shares of cruise ship stocks are trading higher Friday amid sympathy with Carnival after the company reported fourth quarter financial results.
Via Benzinga · December 19, 2025
A third Avatar movie could mean big money for Disney stock and also boost movie theater stocks.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the company initiated a reverse stock split.
Via Benzinga · December 19, 2025
U.S. stocks pushed higher on Friday as investors continued to show optimism towards the AI theme and positioned into December's "triple witching" session.
Via Benzinga · December 19, 2025
Markets are volatile, AI rally shows cracks, outlook uncertain. Technical analysis used to predict short-term moves. 5 stocks to sell before New Year.
Via Benzinga · December 19, 2025
Analysts lift FedEx price forecasts following Q4 earnings beat, citing better-than-expected Express margins and ongoing domestic package service strength.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Altimmune reports positive 48-week Phase 2b data for pemvidutide in MASH, showing fibrosis improvement, weight loss, and strong tolerability.
Via Benzinga · December 19, 2025
BlackBerry (BB) stock falls despite beating earnings and raising outlook, as investors focus on slowing QNX growth and cautious analyst take.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash runway through 2027.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Impact On Carry Trade
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
On-chain data shows Ethereum (CRYPTO: ETH) remains the blockchain with the fastest wallet growth, followed by XRP
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Nike "is still struggling to gain traction and continues to take longer," Needham analyst Tom Nikic wrote in a note.
Via Benzinga · December 19, 2025
Accenture's Q1 earnings call reveals steady increase in client demand for AI projects, but acknowledges early stages and limited scale.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Darden slipped after a slight earnings-per-share miss, even as analysts kept upbeat targets and pointed to steady demand signals.
Via Benzinga · December 19, 2025
Sony's entertainment units agreed to buy WildBrain's stake, lifting Sony's indirect Peanuts ownership to a controlling level, pending approvals.
Via Benzinga · December 19, 2025
Stocks rallied yesterday as softer inflation data hit the tape, but Nike's latest report raises fresh questions about global demand.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Vuzix expands in defense tech through extended collaboration with Collins Aerospace and RTX, progressing towards operational readiness.
Via Benzinga · December 19, 2025
Carnival Corporation & plc (NYSE: CCL) reported strong earnings and record revenue for 2025, driven by demand and cost controls.
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Cassava Sciences confirms an FDA clinical hold on its simufilam epilepsy trial, delaying plans and requiring more data despite strong cash reserves.
Via Benzinga · December 19, 2025
CarMax plans to lower prices and increase ad spend after reporting in-line Q3 results. Analyst reduced PT to $36, maintains Equal-Weight.
Via Benzinga · December 19, 2025
XRP (CRYPTO: XRP) slipping below the $2 mark signals near-term weakness, even as technical indicators begin to hint at a
Via Benzinga · December 19, 2025
Birkenstock Holding reported strong Q4 results, but forex and tariffs dampened margins. What does a Guggenheim Securities analyst think?
Via Benzinga · December 19, 2025
Betting markets now put the odds of a U.S. military move in Venezuela above 50% by early 2026. Oil prices remain near multi-year lows.
Via Benzinga · December 19, 2025
CoreWeave shares are trading higher Thursday after the company announced it joined the Department of Energy's Genesis Mission.
Via Benzinga · December 19, 2025
Bitcoin (CRYPTO: BTC) remains range-bound below $90,000 as on-chain data points to a growing supply–demand mismatch rather than a
Via Benzinga · December 19, 2025
Via Benzinga · December 19, 2025
Shares of Oracle Corporation are trading higher Friday after reports confirmed the technology company will be one of TikTok's new owners.
Via Benzinga · December 19, 2025
Shares of Safe & Green Holdings Corp. (NASDAQ: SGBX) are on watch Friday after the construction engineering company acquired Giant Holdings.
Via Benzinga · December 19, 2025
BioMarin acquires Amicus for $4.8B, expanding its rare disease portfolio with Fabry and Pompe therapies, in a deal expected to close Q2 2026.
Via Benzinga · December 19, 2025
